Journal
BLOOD
Volume 137, Issue 19, Pages 2621-2633Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood.2020007445
Keywords
-
Categories
Funding
- National Institutes of Health, National Cancer Institute [P30 CA076292, K23-CA201594]
- John Morroni Pinellas County First Responders Ball
- Tianjin University
Ask authors/readers for more resources
This study found that in LBCL tumors, IFN signaling is associated with the expression of immune checkpoint ligands, and it is related to lack of durable response to CAR-T therapy. Immune dysregulation promotes axi-cel resistance via multiple mechanistic programs, including insufficient axi-cel expansion due to circulating M-MDSC and tumor IFN signaling.
Axicabtagene ciloleucel (axi-cel) is a chimeric antigen receptor (CAR) T-cell therapy for relapsed or refractory large B-cell lymphoma (LBCL). This study evaluated whether immune dysregulation, present before CAR T-cell therapy, was associated with treatment failure. Tumor expression of interferon (IFN) signaling, high blood levels of monocytic myeloidderived suppressor cells (M-MDSCs), and high blood interleukin-6 and ferritin levels were each associated with a lack of durable response. Similar to other cancers, we found that in LBCL tumors, IFN signaling is associated with the expression of multiple checkpoint ligands, including programmed cell death-ligand 1, and these were higher in patients who lacked durable responses to CAR-T therapy. Moreover, tumor IFN signaling and blood M-MDSCs associated with decreased axi-cel expansion. Finally, patients with high tumor burden had higher immune dysregulation with increased serum inflammatory markers and tumor IFN signaling. These data support that immune dysregulation in LBCL promotes axi-cel resistance via multiple mechanistic programs: insufficient axi-cel expansion associated with both circulating M-MDSC and tumor IFN signaling, which also gives rise to expression of immune checkpoint ligands.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available